Across TCGA pan-cancer cohorts, SNX19P1 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of SNX19P1’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where SNX19P1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types SNX19P1 is over-expressed in tumor.

BRCA, PRAD, and LUSC are the cancer types where SNX19P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SNX19P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	Female	All	+0.178	<.001	6	view →
PRAD	All	All	+0.038	.018	2	view →
LUSC	All	All	+0.007	.012	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: SNX19P1 RNA expression & survival · all SNX19P1 data types